Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Vaccine Plant is a state-owned pharmaceutical facility in Debrecen, Hungary, established to secure the country's domestic vaccine supply. The project was accelerated during the COVID-19 pandemic to develop and manufacture a proprietary Hungarian coronavirus vaccine. Beyond COVID-19, the plant is designed to produce seasonal influenza vaccines and other essential immunizations. It functions as a strategic asset for national health security, leveraging partnerships with the University of Debrecen for research and development. The facility aims to provide a flexible manufacturing platform capable of responding to future pandemic threats while ensuring independence from international supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hungarian government national vaccine plant.